Crinetics Pharmaceuticals, Inc. Accounts Payable
Crinetics Pharmaceuticals, Inc. (CRNX) had Accounts Payable of $13.25 million as of 2026-06-30, per its 10-Q filed 2026-08-03.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current
us-gaap:AccountsPayableCurrent · last filed 2026-08-03
- 2026-06-30: Accounts Payable, Current $13.25M.
- 2026-03-31: Accounts Payable, Current $12.88M.
- 2025-12-31: Accounts Payable, Current $22.61M.
- 2025-09-30: Accounts Payable, Current $6.11M.
| Period end | Accounts Payable, Current |
|---|---|
| 2026-06-30 | $13.25M 10-Q · filed 2026-08-03 |
| 2026-03-31 | $12.88M 10-Q · filed 2026-05-07 |
| 2025-12-31 | $22.61M 10-Q · filed 2026-08-03 |
| 2025-09-30 | $6.11M 10-Q · filed 2025-11-06 |
| 2025-06-30 | $11.32M 10-Q · filed 2025-08-07 |
| 2025-03-31 | $9.84M 10-Q · filed 2025-05-08 |
| 2024-12-31 | $5.85M 10-K · filed 2026-02-26 |
| 2024-09-30 | $4.94M 10-Q · filed 2024-11-12 |
| 2024-06-30 | $8.87M 10-Q · filed 2024-08-08 |
| 2024-03-31 | $10.76M 10-Q · filed 2024-05-09 |
| 2023-12-31 | $6.55M 10-K · filed 2025-02-27 |
| 2023-09-30 | $5.84M 10-Q · filed 2023-11-07 |
| 2023-06-30 | $4.84M 10-Q · filed 2023-08-08 |
| 2023-03-31 | $5.89M 10-Q · filed 2023-05-09 |
| 2022-12-31 | $6.88M 10-K · filed 2024-02-28 |
| 2022-09-30 | $5.88M 10-Q · filed 2022-11-14 |
| 2022-06-30 | $9.04M 10-Q · filed 2022-08-12 |
| 2021-12-31 | $3.42M 10-K · filed 2023-02-28 |
| 2019-09-30 | $2.11M 10-Q · filed 2019-11-12 |
| 2019-06-30 | $2.71M 10-Q · filed 2019-08-13 |
| 2019-03-31 | $2.00M 10-Q · filed 2019-05-13 |
| 2018-12-31 | $1.46M 10-Q · filed 2019-11-12 |
| 2018-09-30 | $1.40M 10-Q · filed 2018-11-13 |
| 2018-06-30 | $2.60M 10-Q · filed 2018-08-30 |
| 2017-12-31 | $403.00K 10-K · filed 2019-03-13 |